Ind-Swift Laboratories: Family acquires shares after matriarch’s passing

On September 9, 2025, Ind-Swift Laboratories Limited announced a post inter-se acquisition of 249,000 equity shares by the promoter group. This transaction occurred via transmission to the legal heirs of the late Neera Mehta, including Rishav Mehta, Ishav Mehta, and Daksh Mehta. The acquisition relied on an exemption under Regulation 10(1)(g) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

The 249,000 shares represent 0.31% of the total share capital of Ind-Swift Laboratories. While the shares were transferred to a joint account of the three legal heirs, the aggregate total shareholding of the promoters and promoter group remained unchanged after this acquisition.

Prior to the transmission, the late Neera Mehta held 481,057 shares, representing 0.59% of the company's capital. After the transmission, her recorded shareholding adjusted to 232,057 shares or 0.28%, reflecting the shares moved to the legal heirs.